Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo - Wikidata - awgldk - TriplyDB

Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo

Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo

http://www.wikidata.org/entity/Q27684208

about

Structurally Divergent Lithium Catalyzed Friedel-Crafts Reactions on Oxetan-3-ols: Synthesis of 3,3-Diaryloxetanes and 2,3-Dihydrobenzofurans Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach.Synthesis of di-, tri-, and tetrasubstituted oxetanes by rhodium-catalyzed O-H insertion and C-C bond-forming cyclization

P2860

Q37394147-72E9143D-5A3C-45C9-8978-E877723C9854 Q38783320-A1250D86-4DBE-4F0F-9EE6-69067711AC75 Q41637627-4298A93D-ABB5-4DFC-855F-BEFF0D2C453C

P2860

Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo

http://www.wikidata.org/entity/Q27684208

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@ast

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@en

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@nl

type

label

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@ast

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@en

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@nl

prefLabel

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@ast

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@en

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@nl

P1433

Q27684208-79989504-66BA-4AC7-A4C0-E9DD8BF999D7

P1476

Q27684208-C8384CCA-092C-43C9-807E-022A73D8E410

P2093

Q27684208-1E10AD17-F903-41CB-8317-49A115672260

Q27684208-2D31FDCB-A3EC-4BCE-BBAB-E9634601DE00

Q27684208-4F071C48-85C8-4C7B-A693-DFEB30FB97CB

Q27684208-53AE18C2-CDFE-4E60-85B8-F08A0B383FD9

Q27684208-583315C9-A123-42F6-925D-29C2D6ED0BDC

Q27684208-5DB61F41-DA54-4B1D-9141-A101EC1831A9

Q27684208-6246A86F-EDC4-4474-B7CB-96C81C4F6B98

Q27684208-63229EE9-5D93-4688-B50C-A0116FF5D013

Q27684208-709B1DAB-0A58-47C3-8C79-3835F573B501

Q27684208-826228C8-8944-4647-9FAA-D1DABBF2A62A

P2860

Q27684208-1195A5CA-D932-494C-B408-6902DCCF6A2E

Q27684208-298EFE5D-ED63-4947-9254-85DC533A94EC

Q27684208-4C56F01B-F073-4C6F-96AD-F076183171B8

Q27684208-6C3EA519-976C-4DB3-9AD1-FE0D8613396E

Q27684208-8E0F53B5-7011-4A3D-9E68-EF36C8AD8E13

Q27684208-BAA46407-9B94-4A42-A2C4-B7984667464E

Q27684208-C227AE32-6BDE-4791-BB92-D8F17085172F

Q27684208-C375D8D7-0118-4C06-A198-BA39B72D2BCE

Q27684208-D750A6C9-2D5F-4FE3-B1F8-67850AB60983

Q27684208-DB011F1D-2044-4645-BB46-CD773E32A153

P304

Q27684208-8D465595-4069-4EB6-86F0-2A7F4F79CDB4

P31

Q27684208-8F446A4D-2A11-45DE-A1CF-4238AB224085

P356

Q27684208-1A5FECDB-E182-458B-BCC3-D8AF8B6B917B

P433

Q27684208-32BEEBAF-DED0-4531-AF54-89DF143705F8

P478

Q27684208-792F2736-BB3F-4696-8270-284A955A5995

P577

Q27684208-2DF989A5-E67E-4702-A8EA-4109DFDF6C3D

P698

Q27684208-89C57227-7A30-4919-9B4D-75FF34335ECD

P921

Q27684208-479FDA1C-D12B-4D6C-9E5A-ADCB3A831F2C

Q27684208-9E688D06-CC92-4E39-9380-63F4CD08A824

P932

Q27684208-4FB94940-42B8-4764-B15C-4FEE99142EFB

P356

P1433

ACS Medicinal Chemistry Letters

P1476

Structure and Property Based D ...... 2 Kinase with Activity in Vivo

@en

P2093

Alex Hird

http://www.w3.org/2001/XMLSchema#string

Bo Peng

http://www.w3.org/2001/XMLSchema#string

Caroline Rivard-Costa

http://www.w3.org/2001/XMLSchema#string

Christopher R Denz

http://www.w3.org/2001/XMLSchema#string

Claudio Chuaqui

http://www.w3.org/2001/XMLSchema#string

Emma L Cooke

http://www.w3.org/2001/XMLSchema#string

Jamal Carlos Saeh

http://www.w3.org/2001/XMLSchema#string

James E Dowling

http://www.w3.org/2001/XMLSchema#string

Kumar Thakur

http://www.w3.org/2001/XMLSchema#string

Larry Bao

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2

ATP site-directed inhibitors of protein kinase CK2: an update

Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization

A quantitative analysis of kinase inhibitor selectivity

Oxetanes as versatile elements in drug discovery and synthesis.

Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer.

Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer.

Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.

Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells.

P304

800-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML400197U

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24900749

http://www.w3.org/2001/XMLSchema#string

P921

Aagianik kimischri

P932

4027246

http://www.w3.org/2001/XMLSchema#string